Thiogenesis Therapeutics, Corp. (TSXV: TTI)
Canada
· Delayed Price · Currency is CAD 0.620
+0.020 (3.33%)
Dec 20, 2024, 9:30 AM EST
Thiogenesis Therapeutics Market Cap
Thiogenesis Therapeutics has a market cap or net worth of CAD 27.31 million as of December 20, 2024. Its market cap has increased by 8.10% in one year.
Market Cap
27.31M
Enterprise Value
23.16M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.62
Market Cap Chart
Since April 13, 2022, Thiogenesis Therapeutics's market cap has increased from 13.96M to 27.31M, an increase of 95.67%. That is a compound annual growth rate of 28.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 27.31M | -18.31% |
| Dec 29, 2023 | 33.43M | 48.30% |
| Dec 30, 2022 | 22.54M | 61.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bausch + Lomb Corporation | 9.11B |
| Bausch Health Companies Inc. | 3.95B |
| WELL Health Technologies Corp. | 1.77B |
| dentalcorp Holdings Ltd. | 1.64B |
| Tilray Brands, Inc. | 1.64B |
| Curaleaf Holdings, Inc. | 1.59B |
| Sienna Senior Living Inc. | 1.31B |
| Cronos Group Inc. | 1.07B |